However, according to Deng et al., the above abnormalities did not increase in newly diagnosed EMM patients compared to MM, while del 17p involving the TP53 gene showed a significant increase in EMM (34.5 vs 11.9%) (22). The gene discussed is TP53; the disease is Miyoshi myopathy.